Tirzepatide is a dual GIP/GLP-1 receptor agonist — the same active molecule sold under two brands: Mounjaro (for type 2 diabetes) and Zepbound (for weight management and moderate-to-severe sleep apnea). It curbs appetite, slows digestion, and improves blood-sugar control, and it’s given as a weekly injection. It’s prescription-only, and compounded versions are not FDA-approved.
What is tirzepatide?
Tirzepatide is a synthetic peptide that activates two receptors at once — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) — both gut hormones involved in appetite and blood sugar. That dual action is what sets it apart from single-target GLP-1 drugs like semaglutide. For the full mechanism, see how tirzepatide works.
Which brands contain tirzepatide?
Tirzepatide isn’t sold under its own name — it’s the ingredient inside two FDA-approved brands, which differ mainly in their approved use:
Chronic weight management + moderate-to-severe obstructive sleep apnea (in adults with obesity)
Brand vs. compounded tirzepatide
Brand tirzepatide (Mounjaro, Zepbound) is an FDA-approved finished product. Compounded tirzepatide uses the same active molecule but is prepared by compounding pharmacies and is not FDA-approved — the FDA doesn’t review it for safety, effectiveness, or manufacturing quality. It’s often cheaper, but understand that trade-off first.
Price depends on the brand, your insurance, and whether you use a manufacturer savings card, cash-pay telehealth, or (unapproved) compounded routes. See the full price landscape on our tirzepatide cost page, or the route-by-route ranking on the cheapest tirzepatide and tirzepatide price guides.
Tirzepatide dosage & titration
Tirzepatide starts at 2.5 mg once weekly and steps up by 2.5 mg every 4 weeks as tolerated, to a maximum of 15 mg — the same schedule for both Mounjaro and Zepbound. See the full step-by-step tirzepatide dosage chart with what to expect at each dose, missed-dose rules, and how compounded dosing differs.
Is there an oral tirzepatide pill?
No — tirzepatide is injection-only, and there is no oral tirzepatide pill or tablet. Lilly's oral GLP-1 (Foundayo/orforglipron) is a different molecule. See the real oral GLP-1 options and why in our oral tirzepatide explainer.
One molecule, 2 brands — and why that decides your bill
Tirzepatide is sold under 2 US brand names. They are the same active drug, but they are different products with different approved uses — and insurers price the product, not the molecule. That single fact explains most of the confusion in this category.
Zepbound — chronic weight management, plus moderate-to-severe obstructive sleep apnea in adults with obesity.
The practical consequence: asking for the diabetes brand to treat weight is off-label and rarely covered, so it usually costs you the coverage route rather than saving money. The on-label product for your goal is the one plans actually pay for.
The second indication that can bypass an exclusion
Zepbound carries an obstructive-sleep-apnea indication. Because that is not a weight-loss use, it can unlock coverage where a plan excludes weight-loss drugs outright.
Many employer plans carve out weight-loss medication entirely, and Medicare Part D excludes drugs used for weight loss by statute. People in that position often conclude they have no route at all — and that conclusion can be wrong, because the request would be made on the other indication, documented as such. Whether it applies depends on your diagnosis, not on how the drug is marketed. See GLP-1 insurance coverage.
What the trial evidence actually shows
Tirzepatide won the only direct head-to-head against semaglutide — −20.2% versus −13.7% mean weight change over 72 weeks (SURMOUNT-5, N=751, NEJM 2025) — and beat semaglutide 1 mg on A1C and weight in SURPASS-2. That comparator was semaglutide's maximum approved dose at the time, so SURPASS-2 is not a test against semaglutide's highest dosing.
Two caveats worth carrying. Trial doses were titrated to what each participant tolerated, so results reflect real-world use rather than top-dose-versus-top-dose. And “more on average” is a group result — plenty of people do excellently on the drug that came second. Cost, coverage and tolerance decide the individual choice more often than the ranking does.
Practical rules specific to tirzepatide
These numbers belong to tirzepatide and must not be transferred to semaglutide.Applying one molecule's window to the other is a real and common error. Always follow the Instructions for Use for the product in your hand.
Missed a dose: take it within about 4 days, then resume your usual schedule. Past that, skip it and take the next on schedule — never double up.
Changing your dose day: leave at least 72 hours between doses. Moving your dose later is always safe because it only lengthens the gap; it is moving earlier that runs into the minimum.
In-use storage: An in-use Mounjaro or Zepbound pen can be kept up to 21 days — considerably shorter than semaglutide's Ozempic pen, which is the difference that catches travellers out.
Freezing: a pen that has frozen must not be used even if it thawed and looks normal — the damage is invisible. This one is class-wide.
The tirzepatide labels carry an oral-contraceptive instruction: switch to a non-oral method, or add a barrier method, for four weeks after starting and after each dose increase. The semaglutide labels do NOT. If you take an oral contraceptive, this is a difference that matters.
Compounded tirzepatide: what changed
Compounded tirzepatide is not FDA-approved as a finished product, and its strength and purity are not FDA-verified. FDA declared the tirzepatide shortage resolved in December 2024, which narrowed commercial-scale compounding. Patient-specific compounding remains permitted in narrow circumstances, but large-scale production of copies of a commercially available approved drug is a different matter.
The cost comparison also inverts once you look past the headline. Insurance essentially never covers compounded drugs, so the cash price is the entire price permanently — no copay to fall back on, no appeal route if it rises, no manufacturer assistance behind it. An approved product that gets covered can drop to a copay, and a denial can be fought. Price the covered route before deciding on the advertised number.
What it costs without insurance
Zepbound self-pay runs $299/mo (2.5 mg), $399/mo (5 mg), then $449/mo (7.5 mg and up) — but only if each refill is purchased within 45 days of the previous one, otherwise $699/mo (10, 12.5, 15 mg). Mounjaro lists at $1,069/mo.
Two traps in this category. Manufacturer copay cards are barred on Medicare, Medicaid and TRICARE — commercial insurance only — which is the most common cause of a surprise bill at the counter. And introductory pricing covers starting doses and early fills, so multiplying it by twelve to budget a year produces a number that does not exist. Ask what you pay at the dose you are titrating toward.
How to get tirzepatide online
Tirzepatide is prescription-only. A licensed clinician — in person or via telehealth — decides whether it’s appropriate and which brand fits. The online path is an online visit, a prescription, and home delivery; a prescription is always required. Compare vetted providers below.
Independent, US-licensed providers that prescribe GLP-1 medications. We compare and link — we never sell medication.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you — it never affects our rankings. How we make money
Tirzepatide is a prescription medicine that activates two gut-hormone receptors — GIP and GLP-1 — which is why it’s called a dual agonist. It reduces appetite, slows stomach emptying, and improves blood-sugar control. It’s the active ingredient in Mounjaro and Zepbound, and it’s given as a weekly injection. This is general information, not medical advice.
Is tirzepatide the same as Mounjaro?
Tirzepatide is the active ingredient in Mounjaro — so Mounjaro is one brand of tirzepatide. The same molecule is also sold as Zepbound, which is FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity, while Mounjaro is approved for type 2 diabetes. Same drug, different approved use.
What’s the difference between tirzepatide and semaglutide?
Tirzepatide activates two receptors (GIP and GLP-1); semaglutide — the ingredient in Ozempic, Wegovy, and Rybelsus — activates one (GLP-1). In head-to-head trials tirzepatide produced more weight loss on average. Tirzepatide is injection-only, while semaglutide also comes as a pill. Which fits is a decision for your prescriber.
Is there a tirzepatide pill?
No. Tirzepatide (Mounjaro and Zepbound) is injection-only, and there is no oral tirzepatide approved or in late-stage trials. If you specifically want a GLP-1 pill, the approved oral options are semaglutide-based: the Ozempic pill for type 2 diabetes (semaglutide tablets, formerly branded Rybelsus) and the Wegovy pill for weight management.
Is compounded tirzepatide the same as brand tirzepatide?
It’s the same active molecule, but compounded tirzepatide is not an FDA-approved finished product — the FDA does not review compounded medicines for safety, effectiveness, or manufacturing quality the way it does brand products. It’s often cheaper, but that trade-off matters; read the risks before considering it.
How do I get tirzepatide online?
Tirzepatide is prescription-only in the US. The usual online route is a licensed telehealth provider: you complete an online visit, and if Mounjaro or Zepbound is appropriate the clinician prescribes it and a pharmacy ships it to you. A prescription is required — avoid any site selling tirzepatide with no consultation. Compare providers and prices before you sign up; cost varies widely by brand, insurance, and pharmacy.